Skip to main content
Donald Cutlip, MD, Cardiology, Boston, MA

Donald E Cutlip MD

Interventional Cardiology


Professor of Medicine, Beth Israel Deaconess Medical Center

Join to view full profile
  • Beth Israel Deaconess Med Ctr330 Brookline Ave Es217Boston, MA 02215

  • Phone+1 617-667-7455

  • Fax+1 617-632-7460

Dr. Cutlip is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1992 - 1996
  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 1979 - 1983
  • University of South Florida College of Medicine
    University of South Florida College of MedicineClass of 1979

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1993 - 2028
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease
  • Interventional Cardiology
    American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Quality Data Center, Massachusetts eHealth Collaborative (MAeHC), 2012-2017
  • CMS Meaningful Use Stage 2 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2012-2017
  • CMS Meaningful Use Stage 1 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2012-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Original Investigations Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents: BIOFLOW V 2-Year Results  
    David E Kandzari, Ron Waksman, Donald E Cutlip, Elie G Gharib, ScienceDirect
  • Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document  
    William F Fearon, John Spertus, Roxana Mehran, Donald Cutlip, Gregg W Stone, Mitchell W Krucoff, European Heart Journal

Lectures

  • Procedural Myocardial Infarction 
    59th Annual Scientific Session & Expo, Atlanta, Georgia, USA
  • Complex Angioplasty: Controversies in Procedural Decision Making 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Authored Content

  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017

Press Mentions

  • Meta-Analysis: Prasugrel the Best P2Y12 Inhibitor After PCI?
    Meta-Analysis: Prasugrel the Best P2Y12 Inhibitor After PCI?June 5th, 2026
  • INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen over Time
    INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen over TimeOctober 29th, 2025
  • INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES over Time
    INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES over TimeOctober 29th, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: